GBN

[1-(AMINOMETHYL)CYCLOHEXYL]ACETIC ACID

Created:	2005-05-19
Last modified:	2020-06-05

Find Related PDB Entry
5 entries where GBN is found as a standalone ligand

Find related ligands: Help
Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	29
Chiral Atom Count	0
Bond Count	29
Aromatic Bond Count	0

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	[1-(AMINOMETHYL)CYCLOHEXYL]ACETIC ACID
Synonyms	GABAPENTIN
Systematic Name (OpenEye OEToolkits)	2-[1-(aminomethyl)cyclohexyl]ethanoic acid
Formula	C₉ H₁₇ N O₂
Molecular Weight	171.237
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	10.04	O=C(O)CC1(CN)CCCCC1
SMILES	CACTVS	3.341	NCC1(CCCCC1)CC(O)=O
SMILES	OpenEye OEToolkits	1.5.0	C1CCC(CC1)(CC(=O)O)CN
Canonical SMILES	CACTVS	3.341	NCC1(CCCCC1)CC(O)=O
Canonical SMILES	OpenEye OEToolkits	1.5.0	C1CCC(CC1)(CC(=O)O)CN
InChI	InChI	1.03	InChI=1S/C9H17NO2/c10-7-9(6-8(11)12)4-2-1-3-5-9/h1-7,10H2,(H,11,12)
InChIKey	InChI	1.03	UGJMXCAKCUNAIE-UHFFFAOYSA-N

Drug Info: DrugBank

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License

DrugBank ID	DB00996
Name	Gabapentin
Groups	investigational approved
Description	Gabapentin is a structural analogue of the inhibitory neurotransmitter gamma-aminobutyric acid ([GABA]) that was first approved for use in the United States in 1993.[L8717] It was originally developed as a novel anti-epileptic for the treatment of certain types of seizures[A186277,A186143] - today it is also widely used to treat neuropathic pain.[A14097,A186179] Gabapentin has some stark advantages as compared with other anti-epileptics, such as a relatively benign adverse effect profile, wide therapeutic index, and lack of appreciable metabolism making it unlikely to participate in pharmacokinetic drug interactions.[A186143,A185981,L8717]. It is structurally and functionally related to another GABA derivative, [pregabalin].
Synonyms	Gabapentin 1-(Aminomethyl)cyclohexaneacetic acid Gabapentino Gabapentina Gabapentinum Gabapentine
Brand Names	Bio-gabapentin Gralise Starter Pack Priva-gabapentin Taro-gabapentin GPL Pak Sig-gabapentin Gabapentin Tablets USP Riva-gabapentin Ipg-gabapentin Gabapentin Kit Ratio-gabapentin Van-gabapentin Gaba 300-EZS Gralise SmartRx Gaba Kit Gabarone Lipritin Mar-gabapentin Pro-gabapentin Pendo-gabapentin Ntp-gabapentin Bci Gabapentin Auro-gabapentin Apo-gabapentin Tablets ACTIVE-PAC with Gabapentin Act Gabapentin Lidotin Neurontin Ag-gabapentin Therapentin-90 Gabacaine Cyclo/Gaba 10/300 Pack Gln-gabapentin Teva-gabapentin Pentican Mylan-gabapentin Gd-gabapentin Nu-gabapentin Capsules Gabapal Gabapentin Capsules USP Jamp Gabapentin Capsules Topical Nerve Pain SmartRx Gaba-V Kit Auro-gabapentin Tablets PMS-gabapentin Relgaabi Lipritin II Gabapentin Capsules Lido GB-300 Prilopentin Nra-gabapentin Gapeam Budibac Ran-gabapentin Jamp-gabapentin Innoprax-5 PHL-gabapentin Apo-gabapentin Fanatrex Gabapentin Dipentocaine Topical Cream Compounding Kit Mint-gabapentin Dom-gabapentin Jamp-gabapentin Tablets Mar-gabapentin Tabs Therapentin-60 Prilopentin -II
Indication	In the United States, gabapentin is officially indicated for the treatment of postherpetic neuralgia in adults and for the adjunctive treatment of partial-onset seizures, with or without secondary generalization, in patients 3 years of age and older.[L8717] In Europe, gabapentin is indicated for adjunctive therapy in the treatment of partial-onset seizures, with or without secondary generalization, in patients 6 years of age and older and as monotherapy in patients 12 years of age and older. It is also used in adults for the treatment of various types of peripheral neuropathic pain, such as painful diabetic neuropathy.[L8732]
Categories	Acids, Acyclic Acids, Carbocyclic Amines Amino Acids Amino Acids, Peptides, and Proteins Aminobutyrates Analgesics Anti-epileptic Agent Anticonvulsants Butyrates Central Nervous System Agents Central Nervous System Depressants Cyclohexanecarboxylic Acids Cyclohexanes Cycloparaffins Decreased Central Nervous System Disorganized Electrical Activity Drugs causing inadvertant photosensitivity Gabapentin and Prodrugs Gabapentinoids Miscellaneous Anticonvulsants Nervous System Neurotransmitter Agents Peripheral Nervous System Agents Photosensitizing Agents Psychotropic Drugs Sensory System Agents Tranquilizing Agents
ATC-Code	N02BF01
CAS number	60142-96-3

Drug Targets

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License

Name	Target Sequence	Pharmacological Action	Actions
Voltage-dependent calcium channel subunit alpha-2/delta-1	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKT...	unknown	inhibitor
Gamma-aminobutyric acid type B receptor subunit 2	MASPRSSGQPGPPPPPPPPPARLLLLLLLPLLLPLAPGAWGWARGAPRPP...	unknown	antagonist
Gamma-aminobutyric acid type B receptor subunit 1	MLLLLLLAPLFLRPPGAGGAQTPNATSEGCQIIHPPWEGGIRYRGLTRDQ...	unknown	antagonist
Voltage-dependent calcium channel subunit alpha-2/delta-2	MAVPARTCGASRPGPARTARPWPGCGPHPGPGTRRPTSGPPRPLWLLLPL...	unknown	inhibitor
Voltage-dependent N-type calcium channel	MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKT...	unknown	inhibitor
Adenosine receptor A1	MPPSISAFQAAYIGIEVLIALVSVPGNVLVIWAVKVNQALRDATFCFIVS...	unknown	agonist
Potassium voltage-gated channel subfamily KQT member 3	MGLKARRAAGAAGGGGDGGGGGGGAANPAGGDAAAAGDEERKVGLAPGDV...	unknown	activator
Potassium voltage-gated channel subfamily KQT member 5	MPRHHAGGEEGGAAGLWVKSGAAAAAAGGGRLGSGMKDVESGRGRVLLNS...	unknown	activator
Branched-chain-amino-acid aminotransferase, cytosolic	MKDCSNGCSAECTGEGGSKEVVGTFKAKDLIVTPATILKEKPDPNNLVFG...	unknown	inhibitor
Large neutral amino acids transporter small subunit 1	MAGAGPKRRALAAPAAEEKEEAREKMLAAKSADGSAPAGEGEGVTLQRNI...	unknown	substrate
View More

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource Name	Reference
Pharos	CHEMBL940
PubChem	6919078, 3446
ChEMBL	CHEMBL940
ChEBI	CHEBI:42797
CCDC/CSD	AVAVAV, AWUWIY01, AWUWIY, IKATIY, QIMKIG06, QIMKOM01, FOXNOW, FOXPOY, YUZTET, AVILOH, QIMKIG03, QIMKIG02, QIMKIG, SOCYUF, QIMKIG05, FOXPAK, NUPXAY, AWUWIY02, QIMKIG01, QIMKOM, QIMKOM02, LORQIT, QIMKIG04, AVILUN, QIMKOM03, FOXPEO
COD	4508983, 7212308, 2016527, 2016526, 2011956, 7053757, 2011957, 7053756